These findings indicated that Gemcitabine enhanced NKG2D ligands through genotoxic stress induced ATM-ATR signaling, while basal expression of NKG2D ligands might be maintained via other mechanisms including EGFR/ PI3K/AKT in NSCLC cells. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.